Q29 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - PhenixFIN Corp

Watchlist Manager

Watchlist

Price: 39.6 EUR 1.02% Market Closed

Market Cap: €80m

	PhenixFIN Corp F:Q29	US
	Milestone Pharmaceuticals Inc NASDAQ:MIST	CA

Profitability Summary

PhenixFIN Corp's profitability score is 43/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

62%

Strong 3Y Average Gross Margin

65%

Declining Gross Margin

73% > 62%

Healthy Operating Margin

25%

Sustainable 3Y Average Operating Margin

23%

Declining Operating Margin

32% > 25%

Healthy Net Margin

19%

Strong 3Y Average Net Margin

54%

Declining Net Margin

134% > 19%

Negative Free Cash Flow Margin

-12%

Negative 3Y Average Free Cash Flow Margin

-89%

Free Cash Flow Margin is Increasing

View All

Hide

Collapse

43 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.